Folinic Acid Interventions in ASD

Summary

This study will assess whether high-dose folinic acid interventions can improve both core symptoms of ASD (i.e., communication, socialization, stereotyped movements) and associated comorbid symptoms (i.e., attention) in a double-blind placebo controlled clinical trial. The study will consist of three phases. Phase 1 and 2 last 12 weeks. If subjects are eligible for phase 3, they have the option of extending the intervention for an additional 24 weeks.

Study Eligibility

Autism Spectrum Disorder, aged 3 years to 9 years 3 months of age, Language Impairment, ability to maintain other complementary, traditional, and/or behavioral treatment interventions constant during the study, Unchanged complementary, traditional, and/or behavioral treatment intervention 8 weeks prior to study.

Contact Name and Number

John Slattery 501-364-3556